- Facing Funding Losses, States Call Out Big Businesses With Employees on Medicaid
- Physician pay drops, ACOs gain under CMS’ 2027 proposal: 8 things to know
- This psychiatric hospital CEO wants to retire the term ‘co-occurring’
- Physician assistant median pay hits $135K: State-by-state breakdown
- AI in the healthcare workforce: 4 notes
- CHOP increased naloxone co-prescribing from 3% to 84%: Study
- HCA now expects up to $1.2B hit from ACA headwinds
- Teladoc named preferred virtual care provider for NBA players union
- Automation Paid Off—So Why Are Denials Still Rising?
- 3 Russians indicted in $62M cybercrime scheme that hit hospitals
- CMS floats 1.68% cut to physician fee schedule, 7 other things to know
- Orthopedic robotics company lands up to $65M in growth capital
- 25 health systems dropping Medicare Advantage plans | 2026
- HCA names divisional CIO
- Minnesota system names interim CEO
- The America medical education system is not behaving as a normal market
- New York awards $6.3M for mental health clubhouses
- Smile Partners USA continues de novo strategy with new practice
- 988 crisis line tops 23M contacts since launch: 5 things to know
- Bipartisan Senate bill targets ASC Medicare reimbursement gap
- Outpatient care to grow 3x faster than inpatient: Report
- Average gross billings for owner dentists surpassed $1M in 2025
- CMS proposes major Medicare reforms to shift physician pay, phase out MIPS and expand ACO participation
- Specialty Dental Brands selects Videa as its AI platform
- States with the most, fewer psychologists per capita
- Oregon State Hospital named in wrongful death lawsuit
- Mobile care DSO Smile America Partners acquired by investment firm
- With FDA approval for its breast cancer blockbuster hopeful, Celcuity could ‘belong in the hands’ of a Big Pharma
- The specialties winning ASC procedure access — and losing on payment
- Anthropic pushes deeper into healthcare with Optum tie-up, UST integration
- FTC, CVS unveil settlement in ongoing insulin pricing case
- Are ASCs still the right investment? 3 orthopedic surgeons make the case
- What physicians miss when selling their ASC
- Why ASCs may not need a $1.5M spine robot
- North Carolina eye surgeon asks for reversal in CON trial
- HHS promises its final rule barring pediatric gender care providers from Medicare is still coming
- FDA issues psychedelic drug clinical trial guidance: 8 things to know
- AMA interoperability initiative brings structured clinical terminology to CPT codes
- Director's Note on What to Expect at the 2026 Partnerships with Sites Summit
- Rising Tide Dental Partners expands network by 22%, appoints COO
- Lettuce Suspected In Growing Multistate Cyclospora Outbreak
- Startup Sonata launches preventive healthcare membership, linking clinical decisions with AI
- Why Are Family Doctors Leaving The Workforce? Retirement, Burnout Creating A U.S. Primary Care 'Brain Drain'
- HCA Healthcare now expects ACA exchange impacts to exceed $1B in 2026
- Huyabio scores with Opdivo combo in 'milestone' skin cancer trial
- Unruly Patients Are Stressing ER Staff, Undermining Care
- Pain Patients Should Taper Opioids At Their Own Pace, Study Suggests
- Heatwaves Raise Hospital Admissions For Mental Health Woes
- U.S. Gun Suicides Hit Record High, Even As Firearm Deaths Decline Overall
- AstraZeneca pays up to $1.5B for EGFR lung cancer drug Zegfrovy from its spinoff Dizal
- Worried About Your Aging Parents? Welcome To The Caregiving Club
- Lawmakers Look To Make Abortion Shield Laws Less Dependent on Who’s Governor
- Knee Pain? Ragged Cartilage? Research Suggests Surgery’s Not the Best Answer
- Real Chemistry builds body of AI healthcare commercialization tools with Anatomi launch
- Inside agency view: Havas SO on authenticity, connection and pushing back against the ‘sea of sameness’
- Why policy gaps threaten behavioral health coverage
- Specialty dentist pay vs. cost of living by state
- HHS, VA sign agreement to advance psychedelic therapy
- What the de novo boom means for DSOs
- Pearl vs. Videa vs. Overjet: what 3 AI giants have accomplished in 2026
- 8 dental Medicaid updates for dentists to know
- What DSO success looks like in the new age of dentistry
- Cellares' recent automated cell therapy wins have 'opened the biotech floodgates'
- Insulet, Calm join forces for diabetes care offerings with ‘Mind in Range’ wellness tools
- Hospital M&A stays hot in Q2 as health systems position for the future
- 13 behavioral health services, facility closures | 2026
- Cottage Health Expands Partnership with hellocare.ai Following Successful Pilot to Deploy AI Assisted Virtual Care and Patient Safety Platform Enterprise Wide
- North Carolina budget allocates millions for first-ever Rural Emergency Hospital reopening
- Payer-backed ad campaign urges lawmakers to reject NSA enforcement bill
- What Is An Aortic Dissection? The Condition That Killed Sen. Lindsey Graham
- Insurers set to pay out $759M in 2026 MLR rebates: KFF
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny
- Germany pushes through healthcare reform package despite pharma's drug discount resistance
- GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- A New Option For Long-Term Care Costs
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Lupin recalls more than 2.5M prescription eye drop bottles, citing possible contamination
- Digital health funding hits $7.4B in 2026 as AI investment reshapes the market
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- Doctors want wearable data but healthcare isn't ready for it, AMA survey finds
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Remarks at the Society for Corporate Governance Conference
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Beyond Benchmarks: Why Trust Must Be Built into Clinical AI Infrastructure
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Weekly Rundown: Surgical Safety Technologies rebrands to Aimbient; UC San Diego launches applied health intelligence institute
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- How Lee Health Turned Language Access into a Strategic Clinical Asset
- Decision readiness is the next AI advantage
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Accountability Is Key to Medicaid's Home Care Future
- Clinical Success Is No Longer One Number
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- 9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- SCAN Health Plan, Alignment Healthcare sue to challenge CMS' MA star ratings recalculations
- Regulatory tracker: Eisai, Biogen scoop up subQ Leqembi starter dose nod
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
Michigan healthcare freedom community forum
23andMe Holding Co. (Nasdaq: ME), announced on March 23rd that it initiated voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri:
https://www.moeb.uscourts.gov/23andme-holding-co-information
Somehow our Attorney General doesn't understand that the 23andMe data delete function only removes the data from public disclosure, but does not actually erase such data. Further, 23andMe genetic data is widely regarded as their most valuable asset and U.S. Bankruptcy Court does not look fondly upon destroying or elucting the assets of a bankrupt:
https://content.govdelivery.com/accounts/MIAG/bulletins/3d8cbad
AG Nessel Urges 23andMe Users to Consider Deleting Accounts Amid BankruptcyBy Danny Wimmer - March 26, 2025
LANSING – Following the Chapter 11 bankruptcy filing of genetic testing company 23andMe on Sunday, March 23, Michigan Attorney General Dana Nessel is urging account holders to consider proactive steps to protect their sensitive personal data.
“23andMe collects and stores some of the most sensitive personal information, our genetic code,” Nessel said. “With the company now in bankruptcy, customers should be aware of the potential risks and consider deleting their accounts to protect their data.”
23andMe is a direct-to-consumer genetic testing company that collects and analyzes genetic code information to provide its customers with ancestry composition data, probable genetic health risks, and other personalized genetic reports. 23andMe also uses the data provided by consumers for medical research and shares this information with pharmaceutical companies for use in drug development, for consumers who have given permission.
While 23andMe has stated that it will continue operating as usual and that there are no changes to how it stores or protects personal data through bankruptcy proceedings, Attorney General Nessel advises Michiganders to consider canceling their accounts and request the destruction of any data or genetic samples maintained by the genetic testing company. The Attorney General has been monitoring the company as part of an investigation into a data breach at 23andMe reported in October 2023 that led to the exposure of the personal information of nearly seven million Americans.
Although high wait times and even portal access disruptions have been reported due to the high volume of customer deletion requests, consumers currently can delete their 23andMe account and personal information with the following steps:
To Delete Genetic Data from 23andMe
1. Log into your 23andMe account on the website.
2. Go to the “Settings” section of your profile.
3. Scroll to a section labeled “23andMe Data” at the bottom of the page.
4. Click “View” next to “23andMe Data”
5. Scroll to the “Delete Data” section.
6. Click “Permanently Delete Data.”
7. Confirm your request; you’ll receive an email from 23andMe; follow the link in the email to confirm your deletion request.To Destroy Your 23andMe Test Sample
If you previously opted to have your saliva sample and DNA stored by 23andMe but want to change that preference, you can do so from your account settings page under “Preferences.”
To Revoke Permission for Your Genetic Data to be Used for Research
If you previously consented to 23andMe and third-party researchers to use your genetic data and sample for research, you may withdraw consent from the account settings page under “Research and Product Consents.”
Customers can find additional information on the 23andMe website. As of the timing of this alert, the company has posted information about how consumers’ information can be permanently deleted.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























